Day One Biopharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Joyce Zhou, Priyanka Grover, and Rati Pinge.
Our next presenting company is Day One. Presenting on behalf of the company, we have CEO, Jeremy Bender.
Good afternoon, everybody. Thank you, Anupam, and thanks to the JPMorgan team for the opportunity to be here today. I also welcome all of you in the audience as well as those listening in. My name is Jeremy Bender. I'm CEO of Day One Biopharmaceuticals.
Excited for the opportunity to tell you about the company today. Joining me are a few colleagues, Lauren Merendino, our CCO; Charles York, our COO and CFO; and Mike Vasconcelles, our Head of R&D. A quick reminder that I will be making forward-looking statements during the presentation today.
We at Day One,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

